Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
| 
                        Date
                        Company Name
                     | Round | Money Raised | Industry | Lead Investor | 
|---|---|---|---|---|
| 
                      Nov 14, 2022
                      
                            Bangyao Biological | Series B | — | Biopharma | — | 
| 
                      Nov 26, 2021
                      
                            Reading Technology | Series A | — | Artificial Intelligence | — | 
| 
                      May 6, 2021
                      
                            Just Medical | Series B | ¥220M | Health Care | — | 
| 
                      Jan 1, 2016
                      
                            Triastek | Seed | — | 3D Printing | Yes |